Tiger Brokers

BUZZ-Xilio rises after surprise quarterly profit

Reuters
Yesterday
BUZZ-Xilio rises after surprise quarterly profit

** Shares of drug developer Xilio Therapeutics XLO.O rise 3.18% to $8.11 premarket

** Co posts Q4 profit of 81 cents per share, while analysts were expecting loss of $1.68 per share - data compiled by LSEG

** Posts Q4 revenue of $13.7 million vs estimate of $7.9 million

** Says quarterly revenue rose on higher collaboration and license revenue, driven by its AbbVie collaboration and Gilead license agreement

** XLO shares were down over 32% in 2025

(Reporting by Kunal Das in Bengaluru)

((Kunal.Das2@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10